Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction

David Carrick, Caroline Haig, Jaclyn Carberry, Vannesa Teng Yue May, Peter McCartney, Paul Welsh, Nadeem Ahmed, Margaret McEntegart, Mark C Petrie, Hany Eteiba, Mitchell Lindsay, Stuart Hood, Stuart Watkins, Ahmed Mahrous, Samuli Mo Rauhalammi, Ify Mordi, Ian Ford, Aleksandra Radjenovic, Naveed Sattar, Keith G Oldroyd, Colin Berry, David Carrick, Caroline Haig, Jaclyn Carberry, Vannesa Teng Yue May, Peter McCartney, Paul Welsh, Nadeem Ahmed, Margaret McEntegart, Mark C Petrie, Hany Eteiba, Mitchell Lindsay, Stuart Hood, Stuart Watkins, Ahmed Mahrous, Samuli Mo Rauhalammi, Ify Mordi, Ian Ford, Aleksandra Radjenovic, Naveed Sattar, Keith G Oldroyd, Colin Berry

Abstract

Background: Failed myocardial reperfusion is common and prognostically important after acute ST-elevation myocardial infarction (STEMI). The purpose of this study was to investigate coronary flow reserve (CFR), a measure of vasodilator capacity, and the index of microvascular resistance (IMR; mmHg × s) in the culprit artery of STEMI survivors.

Methods: IMR (n = 288) and CFR (n = 283; mean age [SD], 60 [12] years) were measured acutely using guide wire-based thermodilution. Cardiac MRI disclosed left ventricular pathology, function, and volumes at 2 days (n = 281) and 6 months after STEMI (n = 264). All-cause death or first heart failure hospitalization was independently adjudicated (median follow-up 845 days).

Results: Myocardial hemorrhage and microvascular obstruction occurred in 89 (42%) and 114 (54%) patients with evaluable T2*-MRI maps. IMR and CFR were associated with microvascular pathology (none vs. microvascular obstruction only vs. microvascular obstruction and myocardial hemorrhage) (median [interquartile range], IMR: 17 [12.0-33.0] vs. 17 [13.0-39.0] vs. 37 [21.0-63.0], P < 0.001; CFR: 1.7 [1.4-2.5] vs. 1.5 [1.1-1.8] vs. 1.4 [1.0-1.8], P < 0.001), whereas thrombolysis in myocardial infarction blush grade was not. IMR was a multivariable associate of changes in left ventricular end-diastolic volume (regression coefficient [95% CI] 0.13 [0.01, 0.24]; P = 0.036), whereas CFR was not (P = 0.160). IMR (5 units) was a multivariable associate of all-cause death or heart failure hospitalization (n = 30 events; hazard ratio [95% CI], 1.09 [1.04, 1.14]; P < 0.001), whereas CFR (P = 0.124) and thrombolysis in myocardial infarction blush grade (P = 0.613) were not. IMR had similar prognostic value for these outcomes as <50% ST-segment resolution on the ECG.

Conclusions: IMR is more closely associated with microvascular pathology, left ventricular remodeling, and health outcomes than the angiogram or CFR.

Trial registration: NCT02072850.

Funding: A British Heart Foundation Project Grant (PG/11/2/28474), the National Health Service, the Chief Scientist Office, a Scottish Funding Council Senior Fellowship, a British Heart Foundation Intermediate Fellowship (FS/12/62/29889), and a nonfinancial research agreement with Siemens Healthcare.

Figures

Figure 1. Three patients with acute ST-elevation…
Figure 1. Three patients with acute ST-elevation myocardial infarction treated by primary percutaneous coronary intervention and with the same antithrombotic therapies, including aspirin, clopidogrel, heparin, and glycoprotein IIbIIIa inhibitor therapy with tirofiban.
Each patient had successful primary percutaneous coronary intervention (PCI), as evidenced by normal thrombolysis in myocardial infarction (TIMI) flow grade 3 the end of the procedure. Cardiac MRI was performed for each patient 2 days later. Coronary artery function was measured in 283 patients, of whom 281 (99%) had cardiac MRI and 213 (75%) had T2* MRI for assessment of myocardial hemorrhage. Top: A patient with normal index of microvascular resistance (IMR 2.0), and no evidence of microvascular injury on MRI. A diagnostic guide wire study of microvascular function in the territory of the culprit coronary artery immediately after primary PCI. IMR and CFR measurements were derived from coronary thermodilution. Microvascular function was normal (IMR 12, CFR 2.6), indicating successful myocardial reperfusion. Two days later, MRI ruled out myocardial hemorrhage (middle right image) or microvascular obstruction (right). Middle: A patient with normal IMR, low CFR, and microvascular obstruction but no hemorrhage on MRI 2 days later. The diagnostic guide wire study of culprit artery microvascular function at the end of primary PCI indicated an abnormal CFR (0.9) but a preserved IMR (11). Late gadolinium contrast-enhanced MRI revealed microvascular obstruction (right image, blue arrow). Bottom: A patient with high IMR, low CFR, and hemorrhagic infarction on MRI. The diagnostic guide wire study of culprit microvascular function immediately after primary PCI indicated severe microcirculatory dysfunction (IMR 89, CFR 1.0). T2*-MRI (middle right image) revealed myocardial hemorrhage (red arrow) within the infarct core. Contrast-enhanced MRI revealed microvascular obstruction (right image, red arrow) within the bright area of infarction. The microvascular obstruction within the infarct core spatially corresponded with the myocardial hemorrhage.
Figure 2. CONSORT flow diagram of the…
Figure 2. CONSORT flow diagram of the cohort study.
STEMI, ST-elevation myocardial infarction; CMR, cardiac magnetic resonance; CFR, coronary flow reserve; IMR, index of microvascular resistance.
Figure 3. An index of microvascular resistance…
Figure 3. An index of microvascular resistance and coronary flow reserve according to the presence or absence of myocardial hemorrhage and microvascular obstruction.
Top: An index of microvascular resistance (IMR) and coronary flow reserve (CFR) according to the presence (n = 89 [42%]) or absence (n = 124 [58%]) of myocardial hemorrhage in 213 participants who had T2* mapping with MRI 2 days after reperfusion. IMR was higher and CFR was lower in patients with myocardial hemorrhage (T2*MRI positive) compared to that in patients without myocardial hemorrhage (T2* MRI negative). Bottom: IMR and CFR according to the presence (n = 25) or absence of microvascular obstruction (n = 99) in the subset of patients from above without myocardial hemorrhage (n = 124 [58%]). In this subset of patients with less severe vascular injury, IMR was similar in patients with or without microvascular obstruction (MVO), as revealed by contrast-enhanced MRI. By contrast, CFR was lower in patients with MVO compared to CFR in patients without MVO. Mann-Whitney tests were used for the statistical analysis. In box-and-whisker plots, horizontal bars indicate the medians, boxes indicate 25th to 75th percentiles, and whiskers indicate 10th and 90th percentiles.

References

    1. O’Gara PT, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):e362–e425. doi: 10.1161/CIR.0b013e3182742cf6.
    1. Mozaffarian D, et al. Heart disease and stroke statistics — 2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322. doi: 10.1161/CIR.0000000000000152.
    1. Levine GN, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol. 2011;58(24):e44–122. doi: 10.1016/j.jacc.2011.08.007.
    1. British Cardiovascular Intervention Society Audit for Adult Cardiovascular Interventions. [April 8, 2016];BCIS Web site.
    1. Carrick D, et al. Prognostic significance of infarct core pathology revealed by quantitative non-contrast in comparison with contrast cardiac magnetic resonance imaging in reperfused ST-elevation myocardial infarction survivors. Eur Heart J. 2016;37(13):1044–1059. doi: 10.1093/eurheartj/ehv372.
    1. Robbers LF, et al. Magnetic resonance imaging-defined areas of microvascular obstruction after acute myocardial infarction represent microvascular destruction and haemorrhage. Eur Heart J. 2013;34(30):2346–2353. doi: 10.1093/eurheartj/eht100.
    1. Ahmed N, Carrick D, Layland J, Oldroyd KG, Berry C. The role of cardiac magnetic resonance imaging (MRI) in acute myocardial infarction (AMI) Heart Lung Circ. 2013;22(4):243–255. doi: 10.1016/j.hlc.2012.11.016.
    1. Carrick D, Berry C. Prognostic importance of myocardial infarct characteristics. Eur Heart J Cardiovasc Imaging. 2013;14(4):313–315. doi: 10.1093/ehjci/jes296.
    1. Frohlich GM, Meier P, White SK, Yellon DM, Hausenloy DJ. Myocardial reperfusion injury: looking beyond primary PCI. Eur Heart J. 2013;34(23):1714–1722. doi: 10.1093/eurheartj/eht090.
    1. Chen J, Hsieh AF, Dharmarajan K, Masoudi FA, Krumholz HM. National trends in heart failure hospitalization after acute myocardial infarction for Medicare beneficiaries: 1998–2010. Circulation. 2013;128(24):2577–2584. doi: 10.1161/CIRCULATIONAHA.113.003668.
    1. Ganame J, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009;30(12):1440–1449. doi: 10.1093/eurheartj/ehp093.
    1. Eitel I, et al. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction. Circ Cardiovasc Imaging. 2011;4(4):354–362. doi: 10.1161/CIRCIMAGING.110.960500.
    1. van Kranenburg M, et al. Prognostic value of microvascular obstruction and infarct size, as measured by CMR in STEMI patients. JACC Cardiovasc Imaging. 2014;7(9):930–939. doi: 10.1016/j.jcmg.2014.05.010.
    1. de Waha S, et al. Impact of early vs. late microvascular obstruction assessed by magnetic resonance imaging on long-term outcome after ST-elevation myocardial infarction: a comparison with traditional prognostic markers. Eur Heart J. 2010;31(21):2660–2668. doi: 10.1093/eurheartj/ehq247.
    1. van ‘t Hof AW, Liem A, Suryapranata H, Hoorntje JC, de Boer MJ, Zijlstra F. Angiographic assessment of myocardial reperfusion in patients treated with primary angioplasty for acute myocardial infarction: myocardial blush grade. Zwolle Myocardial Infarction Study Group. Circulation. 1998;97(23):2302–2306. doi: 10.1161/01.CIR.97.23.2302.
    1. Gibson CM, et al. Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation. 2000;101(2):125–130. doi: 10.1161/01.CIR.101.2.125.
    1. Barbato E, et al. Validation of coronary flow reserve measurements by thermodilution in clinical practice. Eur Heart J. 2004;25(3):219–223. doi: 10.1016/j.ehj.2003.11.009.
    1. Gould KL, Hamilton GW, Lipscomb K, Ritchie JL, Kennedy JW. Method for assessing stress-induced regional malperfusion during coronary arteriography. Experimental validation and clinical application. Am J Cardiol. 1974;34(5):557–564. doi: 10.1016/0002-9149(74)90127-1.
    1. Fearon WF, et al. Microvascular resistance is not influenced by epicardial coronary artery stenosis severity: experimental validation. Circulation. 2004;109(19):2269–2272. doi: 10.1161/01.CIR.0000128669.99355.CB.
    1. Ng MK, Yeung AC, Fearon WF. Invasive assessment of the coronary microcirculation: superior reproducibility and less hemodynamic dependence of index of microcirculatory resistance compared with coronary flow reserve. Circulation. 2006;113(17):2054–2061. doi: 10.1161/CIRCULATIONAHA.105.603522.
    1. Johnson NP, Kirkeeide RL, Gould KL. Coronary anatomy to predict physiology: fundamental limits. Circ Cardiovasc Imaging. 2013;6(5):817–832. doi: 10.1161/CIRCIMAGING.113.000373.
    1. Cuculi F, et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2014;64(18):1894–1904. doi: 10.1016/j.jacc.2014.07.987.
    1. Fearon WF, et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation. 2013;127(24):2436–2441. doi: 10.1161/CIRCULATIONAHA.112.000298.
    1. McGeoch R, et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2010;3(7):715–722. doi: 10.1016/j.jcin.2010.04.009.
    1. Neumann FJ, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation. 1995;92(4):748–755. doi: 10.1161/01.CIR.92.4.748.
    1. Guillen I, Blanes M, Gomez-Lechon MJ, Castell JV. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. Am J Physiol. 1995;269(2 pt 2):R229–R235.
    1. Echavarria-Pinto M, et al. Disturbed coronary hemodynamics in vessels with intermediate stenoses evaluated with fractional flow reserve: a combined analysis of epicardial and microcirculatory involvement in ischemic heart disease. Circulation. 2013;128(24):2557–2566. doi: 10.1161/CIRCULATIONAHA.112.001345.
    1. Payne AR, et al. Microvascular resistance predicts myocardial salvage and infarct characteristics in ST-elevation myocardial infarction. J Am Heart Assoc. 2012;1(4):e002246.
    1. Sezer M, et al. Concurrent microvascular and infarct remodeling after successful reperfusion of ST-elevation acute myocardial infarction. Circ Cardiovasc Interv. 2010;3(3):208–215. doi: 10.1161/CIRCINTERVENTIONS.109.891739.
    1. Ahmed N, et al. Safety of guidewire-based measurement of fractional flow reserve and the index of microvascular resistance using intravenous adenosine in patients with acute or recent myocardial infarction. Int J Cardiol. 2015;202:305–310.
    1. Carrick D, et al. Myocardial hemorrhage after acute reperfused ST-segment-elevation myocardial infarction: relation to microvascular obstruction and prognostic significance. Circ Cardiovasc Imaging. 2016;9(1):e004148. doi: 10.1161/CIRCIMAGING.115.004148.
    1. van de Hoef TP, et al. Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ Cardiovasc Interv. 2014;7(3):301–311. doi: 10.1161/CIRCINTERVENTIONS.113.001049.
    1. Fearon WF, et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2008;51(5):560–565. doi: 10.1016/j.jacc.2007.08.062.
    1. Kitabata H, et al. Coronary microvascular resistance index immediately after primary percutaneous coronary intervention as a predictor of the transmural extent of infarction in patients with ST-segment elevation anterior acute myocardial infarction. JACC Cardiovasc Imaging. 2009;2(3):263–272. doi: 10.1016/j.jcmg.2008.11.013.
    1. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15:91.
    1. Carrick D, et al. Pathophysiology of LV remodeling in survivors of STEMI: inflammation, remote myocardium, and prognosis. JACC Cardiovasc Imaging. 2015;8(7):779–789. doi: 10.1016/j.jcmg.2015.03.007.
    1. Giri S, et al. T2 quantification for improved detection of myocardial edema. J Cardiovasc Magn Reson. 2009;11:56.
    1. Verhaert D, et al. Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging. 2011;4(3):269–278. doi: 10.1016/j.jcmg.2010.09.023.
    1. Kellman P, Arai AE, McVeigh ER, Aletras AH. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med. 2002;47(2):372–383. doi: 10.1002/mrm.10051.
    1. Flett AS, et al. Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging. 2011;4(2):150–156. doi: 10.1016/j.jcmg.2010.11.015.
    1. Eitel I, et al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction. J Am Coll Cardiol. 2010;55(22):2470–2479. doi: 10.1016/j.jacc.2010.01.049.
    1. Berry C, et al. Magnetic resonance imaging delineates the ischemic area at risk and myocardial salvage in patients with acute myocardial infarction. Circ Cardiovasc Imaging. 2010;3(5):527–535. doi: 10.1161/CIRCIMAGING.109.900761.
    1. Payne AR, et al. Bright-blood T2-weighted MRI has higher diagnostic accuracy than dark-blood short tau inversion recovery MRI for detection of acute myocardial infarction and for assessment of the ischemic area at risk and myocardial salvage. Circ Cardiovasc Imaging. 2011;4(3):210–219. doi: 10.1161/CIRCIMAGING.110.960450.
    1. Francone M, et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. J Am Coll Cardiol. 2009;54(23):2145–2153. doi: 10.1016/j.jacc.2009.08.024.
    1. Ghugre NR, et al. Quantitative tracking of edema, hemorrhage, and microvascular obstruction in subacute myocardial infarction in a porcine model by MRI. Magn Reson Med. 2011;66(4):1129–1141. doi: 10.1002/mrm.22855.
    1. Kandler D, et al. The relation between hypointense core, microvascular obstruction and intramyocardial haemorrhage in acute reperfused myocardial infarction assessed by cardiac magnetic resonance imaging. Eur Radiol. 2014;24(12):3277–3288. doi: 10.1007/s00330-014-3318-3.
    1. O’Regan DP, Ariff B, Neuwirth C, Tan Y, Durighel G, Cook SA. Assessment of severe reperfusion injury with T2* cardiac MRI in patients with acute myocardial infarction. Heart. 2010;96(23):1885–1891. doi: 10.1136/hrt.2010.200634.
    1. Anderson LJ, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22(23):2171–2179. doi: 10.1053/euhj.2001.2822.
    1. Steg PG, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012;33(20):2569–2619. doi: 10.1093/eurheartj/ehs215.
    1. Murray ET, et al. Overweight across the life course and adipokines, inflammatory and endothelial markers at age 60-64 years: evidence from the 1946 birth cohort. Int J Obes (Lond) 2015;39(6):1010–1018. doi: 10.1038/ijo.2015.19.
    1. Thygesen K, et al. Third niversal definition of myocardial infarction. Eur Heart J. 2012;33(20):2551–2567. doi: 10.1093/eurheartj/ehs184.
    1. Hicks KA, et al. 2014 ACC/AHA Key Data Elements and Definitions for Cardiovascular Endpoint Events in Clinical Trials: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Cardiovascular Endpoints Data Standards) J Am Coll Cardiol. 2015;66(4):403–469. doi: 10.1016/j.jacc.2014.12.018.

Source: PubMed

Подписаться